Kingdom’s longevity economy is being driven by affluent consumer demand for prevention and optimisation

Saudi Arabia’s consumer longevity market is expanding at approximately 20.7% annually while its geriatric healthcare market is growing at around 6.18% annually. These figures indicate that consumer-facing longevity in the Kingdom is growing at roughly three times the annual rate of national geriatric healthcare. The growth shows where public interest, private capital and technological innovation are moving first. The next step is to ensure that the benefits created by this momentum extend throughout the healthcare system.

Consumers are becoming more proactive about their health. They are seeking earlier diagnostics, personalised nutrition, metabolic optimisation, preventive screening, regenerative medicine, digital monitoring and interventions designed to preserve physical and cognitive performance. This represents a fundamental shift from treating disease after it appears to managing health before serious decline begins. For Saudi Arabia, the benefits extend far beyond individual wellbeing. A strong longevity economy can stimulate biotechnology, artificial intelligence, digital health, precision medicine, medical tourism and advanced clinical research. It can attract international expertise, create highly skilled jobs and support the Kingdom’s broader economic-diversification objectives.

It can also help reduce the future burden of chronic disease. The earlier people address obesity, diabetes, cardiovascular risk, inflammation, reduced mobility and cognitive decline, the greater the opportunity to delay more serious and expensive health complications later in life. In this sense, longevity is not separate from eldercare. It is the first stage of a continuous healthy-ageing pathway. For example, the planned Clinique La Prairie Longevity Health Resort at AMAALA on Saudi Arabia’s Red Sea coast, expected to open in 2027, will combine medicine, nutrition, movement and wellbeing, demonstrating how longevity services can intersect with premium tourism, residential development and preventive healthcare.

Many technologies first introduced through premium longevity and preventive-health services have the potential to deliver benefits across society. Advanced biomarker testing enables earlier identification of chronic-disease risk, while wearable devices provide continuous insight into sleep, movement, cardiovascular function and metabolic health. AI-driven analysis adds another layer of prevention by identifying patterns associated with frailty or hospitalisation before visible deterioration begins.

The same technologies are increasingly relevant to later-life care. Remote-monitoring platforms allow older people to remain independent at home for longer, supported by timely clinical oversight. Personalised nutrition strengthens the management of diabetes and cardiovascular disease, while digital rehabilitation improves recovery following surgery, stroke or injury. Cognitive-assessment tools also support earlier recognition of neurological decline, creating more time for intervention, care planning and family support.

Building a connected healthy-ageing system

Saudi Arabia has an opportunity to build a connected model in which prevention, primary care, specialised medicine, rehabilitation, home healthcare and long-term support function as parts of the same system.

A citizen might begin this journey with preventive screening and personalised health recommendations in middle age. As individual risks change, the same data could support chronic-disease management, medication review, rehabilitation or home monitoring. Later in life, the system could provide coordinated geriatric care without losing the medical history and preventive insights accumulated over previous decades. Such continuity would represent a major improvement over healthcare models that intervene only when people become seriously ill. The longevity boom is also creating a wider investment opportunity. The next generation of successful Saudi longevity companies may not focus only on individual treatments or wellness programmes. They may build the infrastructure connecting prevention with everyday healthcare. This includes platforms for longitudinal health data, remote patient monitoring, integrated diagnostics, home healthcare, rehabilitation, age-friendly housing, caregiver support and personalised chronic-disease management.

Saudi Arabia is also investing directly in the science behind healthy ageing. Riyadh-based Hevolution Foundation committed up to $115 million over five years to 49 projects through the first cohort of its HF-GRO programme, supporting preclinical research in ageing biology and geroscience. This illustrates how the Kingdom’s longevity ambitions are extending beyond consumer services into scientific research and biotechnology development.

There is also a major need for workforce development. Technology can improve efficiency, but healthy ageing still requires geriatricians, nurses, physiotherapists, nutrition specialists, occupational therapists and qualified home-care professionals. Training these specialists should develop alongside investment in diagnostics, artificial intelligence and advanced treatments. Saudi Arabia is particularly well positioned to create this model.

The Kingdom combines substantial investment capacity, strong digital infrastructure, ambitious healthcare reform and a growing public interest in prevention. It also has the ability to connect healthcare, technology, hospitality, urban development and research within a unified longevity strategy. This could position Saudi Arabia not simply as a regional destination for anti-ageing treatments, but as an international centre for healthy-ageing innovation.

Measuring success through healthspan

The real measure of success, however, should not be the number of longevity clinics opened or the number of new optimisation programmes launched. It should be the measurable improvement in population health.

Are people developing chronic diseases later in life? Are older citizens remaining independent for longer? Are preventable hospital admissions declining? Is the period between the onset of serious disease and the end of life becoming shorter?These are the outcomes that transform longevity from a consumer trend into a national health advantage. The Kingdom does not need to choose between longevity and eldercare. It can use the success of one to accelerate the development of the other.